SEATTLE, WA / ACCESSWIRE / July 23, 2024 / Anarti Therapeutics is proud to announce promising data from an in vitro study conducted at Dabur Research Foundation. The results of the study demonstrate a potential biological mechanism of action for Anarti Therapeutics’ Ayurvedic CBD Relief Oil to help relieve chronic pain associated with fibromyalgia. The product is now available for purchase online at https://anarti.us/.
5. Discussion The results of the in vitro study suggest that Anarti’s Relief Oil has potent anti-inflammatory properties. The reduction in pro-inflammatory cytokines (IL-6, IL-8, TNF-α) highlights its potential mechanism of action. These results are consistent with the known benefits of Anarti’s Relief Oil’s active ingredients, including CBD and other natural plant-derived compounds with recognized anti-inflammatory effects. 6. Conclusion The compelling in vitro study results highlight the potential of Anarti’s Relief Oil as an effective anti-inflammatory agent. Anarti’s Relief Oil shows promise as a natural remedy for the management of inflammation and related symptoms, providing a valuable addition to the arsenal of anti-inflammatory treatments.
The full survey results can be found here.
Founder’s Story
Alka Badshah, founder of Anarti Therapeutics, has been battling chronic pain and fatigue caused by fibromyalgia for 25 years. Through extensive research and experimentation with plant-based solutions, she discovered a powerful blend of Ayurveda and CBD that provided pain relief without harmful chemicals. This breakthrough discovery has transformed her quality of life. After experiencing results for five years, she invites you to join the Anarti revolution and experience true pain relief and recovery.
Alka Badshah said, “This achievement has become my life’s purpose. The results found in the study scientifically prove what I have been experiencing for the past five years. There are millions of people who silently suffer from this condition. Every time I hear of someone who has benefited from these products – sleeping better, having days with less pain or regaining activities they had given up – it gives me immense joy and a sense of fulfillment towards my goal of helping people.”
Chronic Pain and Fibromyalgia: A Global Burden
In the United States, approximately 50 million adults suffer from chronic pain, of which approximately 4 million have fibromyalgia. Globally, approximately 1.5 billion people suffer from chronic pain. Fibromyalgia affects 2-4% of the world’s population, affecting approximately 150-300 million people worldwide. These statistics highlight the significant impact that chronic pain and fibromyalgia have on global health. Fibromyalgia is more prevalent in women, with women accounting for 75-90% of diagnosed cases.
Product Availability
Ayurvedic CBD Relief Oil, along with Anarti Therapeutics’ other plant-based therapeutic products, are now available for purchase through the company’s direct-to-consumer store, www.anarti.us .
About Davar Research Foundation
Dabur Research Foundation (DRF) is focused on studying and leveraging the biology of Ayurvedic plants and their active ingredients to develop high-quality, scientifically proven herbal products. With over 100 years of cumulative experience and over 10,000 preclinical studies, DRF has established itself as a key player in the field of research and development. Notable partners include prestigious institutions such as Harvard Medical School, Oxford University, and the Hebrew University of Jerusalem, known for their advancements in cannabis research and development.
About Founder Alka Badshah
Mr. Badshah holds an MS from Massachusetts Institute of Technology (MIT) and has over 20 years of experience in technology and currently lives in Seattle, Washington.
About Anarti Therapeutics
Anarti Therapeutics (Meher LLC dba Anarti Therapeutics, a Western Australian company) is committed to providing innovative plant-based solutions for chronic pain and inflammation. With a focus on scientific research and natural healing, Anarti Therapeutics aims to improve the quality of life for people suffering from chronic pain.
contact address:
Analty Therapeutics
Alka Badshah
Founder/CEO
(425) 442-5560
Email:
Source: Anarti Therapeutics
View Original
press release
At accesswire.com
Copyright 2024 ACCESSWIRE. Unauthorized reproduction prohibited.
